Trade 3SBio Inc. - 1530 CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.10 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023764% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001846% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | HKD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Hong Kong | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.15 |
| Open | 6.15 |
| 1-Year Change | -16.89% |
| Day's Range | 6.1 - 6.2 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 26, 2024 | 6.10 | 0.00 | 0.00% | 6.10 | 6.25 | 6.10 |
| Jul 25, 2024 | 6.15 | -0.05 | -0.81% | 6.20 | 6.25 | 6.10 |
| Jul 24, 2024 | 6.25 | -0.05 | -0.79% | 6.30 | 6.45 | 6.25 |
| Jul 23, 2024 | 6.35 | 0.00 | 0.00% | 6.35 | 6.50 | 6.30 |
| Jul 22, 2024 | 6.40 | 0.10 | 1.59% | 6.30 | 6.50 | 6.30 |
| Jul 19, 2024 | 6.45 | -0.05 | -0.77% | 6.50 | 6.55 | 6.45 |
| Jul 18, 2024 | 6.55 | -0.05 | -0.76% | 6.60 | 6.60 | 6.50 |
| Jul 17, 2024 | 6.55 | 0.10 | 1.55% | 6.45 | 6.60 | 6.45 |
| Jul 16, 2024 | 6.55 | 0.05 | 0.77% | 6.50 | 6.55 | 6.40 |
| Jul 15, 2024 | 6.50 | -0.20 | -2.99% | 6.70 | 6.75 | 6.50 |
| Jul 12, 2024 | 6.70 | 0.10 | 1.52% | 6.60 | 6.75 | 6.55 |
| Jul 11, 2024 | 6.60 | 0.15 | 2.33% | 6.45 | 6.60 | 6.45 |
| Jul 10, 2024 | 6.50 | 0.05 | 0.78% | 6.45 | 6.50 | 6.40 |
| Jul 9, 2024 | 6.45 | 0.20 | 3.20% | 6.25 | 6.45 | 6.25 |
| Jul 8, 2024 | 6.25 | -0.10 | -1.57% | 6.35 | 6.40 | 6.20 |
| Jul 5, 2024 | 6.40 | 0.20 | 3.23% | 6.20 | 6.45 | 6.20 |
| Jul 4, 2024 | 6.30 | -0.10 | -1.56% | 6.40 | 6.40 | 6.25 |
| Jul 3, 2024 | 6.40 | 0.00 | 0.00% | 6.40 | 6.45 | 6.30 |
| Jul 2, 2024 | 6.35 | 0.05 | 0.79% | 6.30 | 6.45 | 6.30 |
| Jun 28, 2024 | 6.30 | 0.10 | 1.61% | 6.20 | 6.35 | 6.15 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
3SBio Company profile
3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals. The company's primary products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; Yisaipu, a tumour necrosis factor for treating rheumatoid arthritis, ankylosing spondylitis, and psoriasis; and EPIAO, a recombinant human erythropoietin for the treatment of anemia associated with chronic kidney disease (CKD), chemotherapy-induced anemia, and reduction of allogeneic blood transfusion in surgery patients. Its primary products also comprise SEPO, a recombinant human erythropoietin for anemia associated with CKD and chemotherapy; Byetta/Bydureon, an exenatide injection to improve glycemic control in adults with type-2 diabetes mellitus; and Qiming Keli for retinopathy caused by type-2 diabetes. In addition, the company offers Ruisiyi to treat advanced breast cancer; Wanwei for treating vomiting caused by cytotoxic chemotherapy; and Intefen to treat lymphatic or hematopoietic malignancies and viral infections. Further, it provides Inleusin for renal cell carcinoma, melanoma, thoracic fluid build-up caused by cancer, and tuberculosis; Etanercept for moderate to severe rheumatoid arthritis and plaque psoriasis, and active ankylosing spondylitis; and Sparin for prophylaxis and vein thrombosis, and to prevent clotting during hemodialysis. Additionally, the company offers Mandi for male-pattern alopecia and alopecia areata; Aiyishu for iron-deficiency anemia; Disu to prevent and treat chronic bronchitis, colds, and asthma; Jiannipai to prevent acute rejection after renal transplantation; and Humulin for diabetes, as well as contract development and manufacturing, trading, project management and consultation, and technology services. The company markets its products through in-house sales and marketing team, as well as distributors and third-party promoters. 3SBio Inc. was incorporated in 2006 and is headquartered in Shenyang, the People's Republic of China.| Industry: | Biopharmaceuticals |
瀋陽經濟技術開發區十號路1甲3號
SHENYANG
LIAONING
CN
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com